Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Finalist for Orange County by Seini Moimoi | Sep 16, 2020 | Portfolio News
89bio Announces Pricing of Upsized Public Offering of Common Stock by Seini Moimoi | Sep 16, 2020 | Portfolio News
CuraSen Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial with First Proprietary Compound, CST-2032, Targeting Neurodegenerative Disease by Seini Moimoi | Sep 15, 2020 | Portfolio News
89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH by Seini Moimoi | Sep 14, 2020 | Portfolio News
Nabriva Therapeutics Granted New Technology Add-On Payment for XENLETA® (lefamulin) and CONTEPO™ (fosfomycin) by Centers for Medicare & Medicaid Services by Seini Moimoi | Sep 10, 2020 | Portfolio News